Infinity Pharmaceuticals Inc
OTC:INFIQ
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.0001
0.006
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one INFIQ stock under the Base Case scenario is 29.044 USD. Compared to the current market price of 0.0001 USD, Infinity Pharmaceuticals Inc is Undervalued by 100%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Infinity Pharmaceuticals Inc
Balance Sheet Decomposition
Infinity Pharmaceuticals Inc
Current Assets | 19.9m |
Cash & Short-Term Investments | 17.7m |
Other Current Assets | 2.2m |
Non-Current Assets | 1.3m |
PP&E | 1.1m |
Other Non-Current Assets | 200k |
Current Liabilities | 12.1m |
Accounts Payable | 1.5m |
Accrued Liabilities | 10.6m |
Non-Current Liabilities | 46.5m |
Other Non-Current Liabilities | 46.5m |
Earnings Waterfall
Infinity Pharmaceuticals Inc
Revenue
|
2.5m
USD
|
Cost of Revenue
|
-1.5m
USD
|
Gross Profit
|
1m
USD
|
Operating Expenses
|
-43m
USD
|
Operating Income
|
-42m
USD
|
Other Expenses
|
1.1m
USD
|
Net Income
|
-40.9m
USD
|
Free Cash Flow Analysis
Infinity Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
INFIQ Profitability Score
Profitability Due Diligence
Infinity Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
Score
Infinity Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
INFIQ Solvency Score
Solvency Due Diligence
Infinity Pharmaceuticals Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Infinity Pharmaceuticals Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INFIQ Price Targets Summary
Infinity Pharmaceuticals Inc
Dividends
Current shareholder yield for INFIQ is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2000-07-27. The firm is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma). Its eganelisib clinical development program includes MAcrophage Reprogramming in Immuno-Oncology-3 (MARIO-3), MARIO-275 and MARIO-1. MARIO-3 is a multi-arm Phase II study designed to evaluate eganelisib in the front-line treatment for both metastatic triple-negative breast cancer (TNBC), and renal cell carcinoma (RCC). MARIO-275 is its global, randomized, placebo-controlled Phase II study evaluating the effect of adding eganelisib to nivolumab, also known as Opdivo, in checkpoint-naive advanced urothelial cancer (UC). MARIO-1 is in the Phase 1/1b clinical study.